Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.

Total number of publications: 7,082

Enter a faculty name:

or browse faculty by school:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

Reset
First Prev 1 2 3 4 5 6 7 8 9 Next Last

  • Citrome, L., & Ketter, T. A. (2015). Number needed to treat can be helpful: A response to Andrade. The Journal of Clinical Psychiatry, 76(9), e1136-e1137. doi:10.4088/JCP.15lr10001

    		•

  • Citrome, L., & Ketter, T. A. (2015). Pharmacotherapy for bipolar depression: Comparative efficacy and acceptability is in the eye of the beholder. Evidence-Based Mental Health, 18(3) [Article 88]. doi:10.1136/eb-2015-102062

  • Citrome, L., & Ketter, T. A. (2016). NNT and NNH remain helpful in evidence-based medicine. The British Journal of Psychiatry, 209(3), 262-263. doi:10.1192/bjp.209.3.262b

    		•

  • Citrome, L., & Magnusson, K. (2014). Paging Dr Cohen, Paging Dr Cohen... An effect size interpretation is required STAT!: visualising effect size and an interview with Kristoffer Magnusson. International Journal of Clinical Practice, 68(5), 533-534. doi:10.1111/ijcp.12435

     

    		•

  • Citrome, L., & Volavka, J. (2014). The psychopharmacology of violence: Making sensible decisions. CNS Spectrums, 19(5), 411-8. doi:10.1017/S1092852914000054

    		•

  • Citrome, L., & Volavka J (2015). Preventing violence in patients with schizophrenia. Current Treatment Options in Psychiatry, 2(2), 182-191. doi:10.1007/s40501-015-0039-4

    		•

  • Citrome, L., Collins, J. M., Nordstrom, L., Rosen, E. J., Baker, R., Nadkarni, A., & Kalsekar, I. (2013). Incidence of cardiovascular outcomes and diabetes mellitus among users of second-generation antipsychotics. Journal of Clinical Psychiatry, 74(12), 1199-1206. doi:10.4088/JCP.13m08642

    		•

  • Citrome, L., Du, Y., Risinger, R., Stankovic, S., Claxton, A., Zummo, J., . . . Ehrich, E. W. (2016). Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia. International Clinical Psychopharmacology, 31(2), 69-75. doi:10.1097/YIC.0000000000000106

    		•

  • Citrome, L., Durgam, S., Lu, K., Ferguson, P., & Laszlovszky, I. (2016). The effect of cariprazine on hostility associated with schizophrenia: Post hoc analyses from 3 randomized controlled trials. The Journal of Clinical Psychiatry, 77(1), 109-115. doi:10.4088/JCP.15m10192

    		•

  • Citrome, L., Eramo, A., Francois, C., Duffy, R., Legacy, S. N., Offord, S. J., . . . Rohman, P. (2015). Lack of tolerable treatment options for patients with schizophrenia. Neuropsychiatric Disease and Treatment, 11, 3095-3104. doi:10.2147/NDT.S91917

    		•

  • Citrome, L., Goldberg, J. F., & Portland, K. B. (2013). Placing transdermal selegiline for major depressive disorder into clinical context: Number needed to treat, number needed to harm, and likelihood to be helped or harmed. Journal of Affective Disorders, 151(2), 409-417. doi:10.1016/j.jad.2013.06.027

    		•

  • Citrome, L., Gommoll, C. P., Tang, X., Nunez, R., & Mathews, M. (2015). Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: Post-hoc analyses of a phase IV trial. International Clinical Psychopharmacology, 30(2), 75-81. doi:10.1097/YIC.0000000000000056 

    		•

  • Citrome, L., Johnston, S., Nadkarni, A., Sheehan, J. J., Kamat, S. A., & Kalsekar, I. (2014). Prevalence of pre-existing risk factors for adverse events associated with atypical antipsychotics among commercially insured and medicaid insured patients newly initiating atypical antipsychotics. Current Drug Safety, 9(3), 227-235. doi:10.2174/1574886309666140601211551

    		•

  • Citrome, L., Kalsekar, I., Baker, R. A., & Hebden, T. (2014). A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults. Current Medical Research and Opinion, 30(8), 1629-1641. doi:10.1185/03007995.2014.908280

    		•

  • Citrome, L., Kalsekar, I., Guo, Z., Laubmeier, K., & Hebden, T. (2013). Diagnoses associated with use of atypical antipsychotics in a commercial health plan: A claims database analysis. Clinical Therapeutics, 35(12), 1867-1875. doi:10.1016/j.clinthera.2013.09.006

    		•

  • Citrome, L., Kamat, S. A., Sapin, C., Baker, R. A., Eramo, A., Ortendahl, J., . . . Gutierrez, B. (2014). Cost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States. Journal of Medical Economics, 17(8), 567-576. doi:10.3111/13696998.2014.917089

    		•

  • Citrome, L., Kando, J., Bliss, C., & Herman, B. (2016). Relationships between the clinical global impressions scale, binge eating days, and the Yale-Brown obsessive compulsive scale modified for binge eating in adults with moderate to severe binge eating disorder in two phase 3 studies. Neuropsychopharmacology, 41(S1), S350-S351.

  • Citrome, L., Karagianis, J., Maguire, G. A., & Nierenberg, A. A. (2014). Pharmaism: a tale of two perspectives   refers to  Int J Clin Pract. 2014 Jun;68(6):662-5. PMID: 24837088; International Journal of Clinical Practice, 68(6), 659-661. doi:10.1111/ijcp.12460

    		•

  • Citrome, L., Ketter, T. A., Cucchiaro, J., & Loebel, A. (2014). Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Journal of Affective Disorders, 155, 20-27. doi:10.1016/j.jad.2013.10.040

    		•

  • Citrome, L., Ota, A., Nagamizu, K., Perry, P., Weiller, E., & Baker, R. (2016). The effect of brexpiprazole (OPC-34712) versus aripiprazole in adult patients with acute schizophrenia: An exploratory study. International Journal of Neuropsychopharmacology, 19(Suppl 1), 40-41. doi:10.1097/YIC.0000000000000123

    		•

  • Citrome, L., Ota, A., Nagamizu, K., Perry, P., Weiller, E., & Baker, R. (2016). Treatment of acute schizophrenia in adult patients using either brexpiprazole (OPC-34712) or aripiprazole, an exploratory study. CNS Spectrums, 21(1), 99.

  • Citrome, L., Ota, A., Nagamizu, K., Perry, P., Weiller, E., & Baker, R. A. (2016). The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: Results from a randomized, exploratory study. International Clinical Psychopharmacology, 31(4), 192-201. doi:10.1097/YIC.0000000000000123

    		•

  • Citrome, L., Peselow, E. D., & Glick, I. D. (2013). Asenapine. In A. F. Schatzenberg & C. B. Nemeroff (Eds.), Essentials of clinical psychopharmacology (3rd ed., pp. 367-375). Arlington, VA: American Psychiatric Publishing.

  • Citrome, L., Stensbol, T. B., & Maeda, K. (2015). The preclinical profile of brexpiprazole: What is its clinical relevance for the treatment of psychiatric disorders? Expert Review of Neurotherapeutics, 15(10), 1219-1229. doi:10.1586/14737175.2015.1086269

    		•

  • Citrome, L., Weiden, P. J., Alva, G., Glick, I. D., Jackson, R., Mattingly, G., . . . Winseck, A. (2015). Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophrenia. Clinical Schizophrenia & Related Psychoses, 8(4), 183-195. doi:10.3371/CSRP.CIWE.103114

    		•
First Prev 1 2 3 4 5 6 7 8 9 Next Last